| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/28/2006 | CA2601400A1 Improvements in or relating to treatment and prevention of viral infections |
| 09/27/2006 | EP1705190A2 Peptide derivatives |
| 09/27/2006 | EP1705183A1 Binding molecules for human factor VIII and factor VIII-like proteins |
| 09/27/2006 | EP1705182A1 Antitumoral and antiviral peptides |
| 09/27/2006 | EP1704868A1 HLA binding peptides and their uses |
| 09/27/2006 | EP1704257A2 Fluorogenic kinase assays and substrates for kinases and phosphatases |
| 09/27/2006 | EP1704160A2 Methods and compositions for identifying rna-binding proteins |
| 09/27/2006 | EP1313754A4 Nucleophile-stable thioester generating compounds, methods of production and use |
| 09/27/2006 | EP1196433B1 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 09/27/2006 | EP1173222B1 Conjugate having a cleavable linkage for use in a liposome |
| 09/27/2006 | EP0759786B1 Somatostatin binding peptide-metal chelate conjugates |
| 09/27/2006 | CN1839150A Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 09/27/2006 | CN1839149A Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 09/27/2006 | CN1838954A Glycogen synthase kinase-3 inhibitors |
| 09/27/2006 | CN1837232A Process for solid phase synthesis of octreotide |
| 09/26/2006 | USRE39308 3,5-dioxa-12-azawurtzitane compound and process of preparing same |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112562 Insulin conjugates and methods of use thereof |
| 09/26/2006 | US7112442 Tryptophan containing low molecular weight polylysine, for use in receptor-mediated and nonreceptor-mediated gene delivery, both in vivo and in vitro |
| 09/26/2006 | US7112438 Binding molecules for human factor VIII and factor VIII-like proteins |
| 09/26/2006 | US7112333 T cell epitopes of ryegrass pollen allergen |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006098463A1 Polynucleic acid-binding substance |
| 09/21/2006 | WO2006097774A1 Synthetic peptides containing unnatural adamantane-related amino acids for use as antitumour drugs |
| 09/21/2006 | WO2006097748A2 Peptide stabilizer compounds and screening method |
| 09/21/2006 | WO2006097693A1 Convergent solid phase peptide synthesis by reaction of two fragments bound to solid support |
| 09/21/2006 | WO2006096963A1 Ionic liquid supported synthesis |
| 09/21/2006 | WO2006055806A3 Diagnostic, prognostic, and therapeutic factor smac/diablo in human cancer |
| 09/21/2006 | WO2006029982A3 Treatment of atherosclerosis |
| 09/21/2006 | WO2002050303A3 Protein-protein interactions |
| 09/21/2006 | US20060211629 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/21/2006 | US20060211626 For treating preterm labor and dysmenorrhea |
| 09/21/2006 | US20060211625 New hybrid oligomers, their preparation process and pharmaceutical compositions containing them |
| 09/21/2006 | US20060211623 Conopeptides |
| 09/21/2006 | US20060211615 Surfactant peptide nanostructures, and uses thereof |
| 09/21/2006 | US20060211607 Somatostatin-dopamine chimeric analogs |
| 09/21/2006 | US20060211603 Ramoplanin derivatives possessing antibacterial activity |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211148 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211147 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211144 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060210573 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines; monoclonal, polyclonal, recombinant, synthetic intact antibody and Fv, F(ab'), F(ab')2 and single chain antibody fragments; polynucleotides |
| 09/21/2006 | US20060210560 TNF receptor action modulaton |
| 09/21/2006 | US20060210493 Peptide that binds to integrins |
| 09/21/2006 | US20060210452 Very large scale immobilized polymer synthesis |
| 09/21/2006 | CA2742202A1 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 09/21/2006 | CA2645003A1 Peptide stabilizer compounds and screening method |
| 09/21/2006 | CA2601227A1 Mecano growth factor peptides and their use |
| 09/20/2006 | EP1702985A2 Preferred segments of neural thread protein and methods of using the same |
| 09/20/2006 | EP1702929A2 Therapeutic use of the smr1 protein and active derivatives thereof |
| 09/20/2006 | EP1527341A4 Interfacial biomaterials |
| 09/20/2006 | EP1521841A4 Method for identifying individual active entities from complex mixtures |
| 09/20/2006 | EP1466179A4 Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same |
| 09/20/2006 | EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them |
| 09/20/2006 | EP0929569B1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/20/2006 | CN1835972A Combination therapy for B cell disorders |
| 09/20/2006 | CN1835970A Peptides enhancing CEH activity or ACAT inhibitory activity, pharmaceutical compositions comrising these peptides and their use in the treatment of atherosclerosis |
| 09/20/2006 | CN1275979C Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof |
| 09/19/2006 | US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 09/19/2006 | US7109303 Modified cytokines for use in cancer therapy |
| 09/19/2006 | US7109172 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/19/2006 | US7109168 Neurotrophic peptides exhibiting increased metabolic stability while retaining biological activity |
| 09/19/2006 | US7109167 Tetrapeptide |
| 09/19/2006 | US7108995 Small peptides having apoptotic activities and their applications |
| 09/14/2006 | WO2006096757A2 Inhibitors of reca activities for control of antibiotic-resistant bacterial pathogens |
| 09/14/2006 | WO2006096207A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 09/14/2006 | WO2006095128A2 Rodent pest control |
| 09/14/2006 | WO2006095041A1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 09/14/2006 | WO2006078268A3 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 09/14/2006 | WO2006070432A3 Anti-tumoral immunogenic peptides and vaccine thereof |
| 09/14/2006 | WO2006061101A3 Drug delivery peptides for crossing blood-brain barrier |
| 09/14/2006 | WO2006014579A3 Enhancing class i antigen presentation with synthetic sequences |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | US20060205923 For detecting the presence of FIV antibodies in a biological sample, bycontacting a biological sample from an animal with the FIV polypeptide |
| 09/14/2006 | US20060205672 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/14/2006 | US20060205670 Anti-angiogenic compounds |
| 09/14/2006 | US20060205669 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 09/14/2006 | US20060205668 For therapy of spinal cord injury or stroke, by overcoming the inhibitory effects of myelin on axonal regeneration |
| 09/14/2006 | US20060205667 Wt1 substitution pepides |
| 09/14/2006 | US20060205666 Gamma-secretase inhibitors |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205637 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 09/14/2006 | US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
| 09/14/2006 | CA2605122A1 Thyrotropin-releasing hormone analogs and method of use |
| 09/14/2006 | CA2601550A1 Method of in-vitro diagnosis of alzheimer's disease by means of a monoclonal antibody |
| 09/14/2006 | CA2600370A1 Bioactive fus1 peptides and nanoparticle-polypeptide complexes |
| 09/14/2006 | CA2599465A1 Antibody based rodenticide |
| 09/14/2006 | CA2575730A1 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 09/13/2006 | EP1700920A1 Synthetic antibiotics |
| 09/13/2006 | EP1700863A1 Means and methods for producing polymers comprising peptide in a side chain |
| 09/13/2006 | EP1700119A1 Beta-lactamase cd4+ t-cell epitopes |
| 09/13/2006 | EP1699815A1 Novel proteasome modulators |
| 09/13/2006 | EP1699813A2 Isozyme-specific antagonists of protein kinase c |
| 09/13/2006 | EP1699809A2 Amniotic-derived peptide and uses thereof |
| 09/13/2006 | EP1699495A2 Conjugates of angiotensin ii and an imaging moiety |
| 09/13/2006 | EP1699460A2 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 09/13/2006 | EP1625152B1 Peptides modulating the activity of the engrailed transcription factor |